Literature DB >> 16793544

Structural basis of DNA recognition by p53 tetramers.

Malka Kitayner1, Haim Rozenberg1, Naama Kessler1, Dov Rabinovich1, Lihi Shaulov2, Tali E Haran3, Zippora Shakked4.   

Abstract

The tumor-suppressor protein p53 is among the most effective of the cell's natural defenses against cancer. In response to cellular stress, p53 binds as a tetramer to diverse DNA targets containing two decameric half-sites, thereby activating the expression of genes involved in cell-cycle arrest or apoptosis. Here we present high-resolution crystal structures of sequence-specific complexes between the core domain of human p53 and different DNA half-sites. In all structures, four p53 molecules self-assemble on two DNA half-sites to form a tetramer that is a dimer of dimers, stabilized by protein-protein and base-stacking interactions. The protein-DNA interface varies as a function of the specific base sequence in correlation with the measured binding affinities of the complexes. The new data establish a structural framework for understanding the mechanisms of specificity, affinity, and cooperativity of DNA binding by p53 and suggest a model for its regulation by regions outside the sequence-specific DNA binding domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16793544     DOI: 10.1016/j.molcel.2006.05.015

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  174 in total

1.  Pliable DNA conformation of response elements bound to transcription factor p63.

Authors:  Chen Chen; Natalia Gorlatova; Osnat Herzberg
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

2.  Structure of p73 DNA-binding domain tetramer modulates p73 transactivation.

Authors:  Abdul S Ethayathulla; Pui-Wah Tse; Paola Monti; Sonha Nguyen; Alberto Inga; Gilberto Fronza; Hector Viadiu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-02       Impact factor: 11.205

3.  Four p(53)s in a pod.

Authors:  Seth Chitayat; Cheryl H Arrowsmith
Journal:  Nat Struct Mol Biol       Date:  2010-04       Impact factor: 15.369

Review 4.  The origins and evolution of the p53 family of genes.

Authors:  Vladimir A Belyi; Prashanth Ak; Elke Markert; Haijian Wang; Wenwei Hu; Anna Puzio-Kuter; Arnold J Levine
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-16       Impact factor: 10.005

5.  Radioprobing the conformation of DNA in a p53-DNA complex.

Authors:  Valeri N Karamychev; Difei Wang; Sharlyn J Mazur; Ettore Appella; Ronald D Neumann; Victor B Zhurkin; Igor G Panyutin
Journal:  Int J Radiat Biol       Date:  2012-06-21       Impact factor: 2.694

6.  Cryo-EM-On-a-Chip: Custom-Designed Substrates for the 3D Analysis of Macromolecules.

Authors:  Nick A Alden; A Cameron Varano; William J Dearnaley; Maria J Solares; William Y Luqiu; Yanping Liang; Zhi Sheng; Sarah M McDonald; John Damiano; Jennifer McConnell; Madeline J Dukes; Deborah F Kelly
Journal:  Small       Date:  2019-04-08       Impact factor: 13.281

Review 7.  The Tail That Wags the Dog: How the Disordered C-Terminal Domain Controls the Transcriptional Activities of the p53 Tumor-Suppressor Protein.

Authors:  Oleg Laptenko; David R Tong; James Manfredi; Carol Prives
Journal:  Trends Biochem Sci       Date:  2016-09-23       Impact factor: 13.807

8.  The DNA-binding domain mediates both nuclear and cytosolic functions of p53.

Authors:  Ariele Viacava Follis; Fabien Llambi; Li Ou; Katherine Baran; Douglas R Green; Richard W Kriwacki
Journal:  Nat Struct Mol Biol       Date:  2014-05-11       Impact factor: 15.369

9.  p53 oligomerization status modulates cell fate decisions between growth, arrest and apoptosis.

Authors:  Nicholas W Fischer; Aaron Prodeus; David Malkin; Jean Gariépy
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

10.  Microchip-Based Structure Determination of Disease-Relevant p53.

Authors:  Maria J Solares; G M Jonaid; William Y Luqiu; Yanping Liang; Madison C Evans; William J Dearnaley; Zhi Sheng; Deborah F Kelly
Journal:  Anal Chem       Date:  2020-10-30       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.